NCT05489731 2023-06-15
VIC-1911
Jiesi Yingda Pharmaceutical Technology (Suzhou) Co., Ltd.
Phase 1 Unknown
Clinical Trials
4 trialsNCT04448379 2020-12-28
Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc.
Phase 1 Unknown
NCT03891615 2020-12-16
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
Massachusetts General Hospital
Phase 1 Unknown
NCT03050411 2017-02-10
Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
Peking University Third Hospital
Phase 1 Unknown